NovaBay Pharmaceuticals I... (NBY)

AI Score

Unlock

0.60

-0.01 (-0.83%)

At close: Mar 03, 2025, 12:03 PM

NovaBay Pharmaceuticals Balance Sheet Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY03
Cash & Equivalents	3.13M	5.36M	7.5M	11.95M	6.94M	3.18M	3.2M	9.51M	2.38M	5.43M	10.5M	12.73M	8.43M	11.53M	10.99M	12.1M	10.94M	4.9M	2.21M	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.55M	4.13M	5.71M	1.27M	300K	n/a	11.41M	6.18M	1M	n/a
Long-Term Investments	n/a	484K	475K	475K	475K	475K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	497K	489K	476K	476K	2K	77K	613K	539K	155K	149K	141K	63K	135K	174K	105K	n/a	n/a	n/a	n/a	n/a
Receivables	759K	1.97M	1.67M	1.11M	1.07M	3.49M	3.71M	2.12M	536K	273K	784K	943K	3K	500K	3.8M	n/a	n/a	n/a	n/a	n/a
Inventory	2.88M	3.44M	3.22M	608K	492K	280K	504K	873K	1.34M	521K	231K	23K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	388K	560K	778K	576K	1.46M	1.65M	1.58M	1.97M	261K	1.46M	1.61M	890K	834K	896K	1.08M	828K	838K	226K	83K	n/a
Total Current Assets	7.15M	11.33M	13.17M	14.24M	9.38M	8.61M	8.99M	14.47M	4.53M	6.95M	14.79M	18.28M	14.56M	13.75M	15.61M	12.51M	22.77M	11.31M	3.29M	n/a
Property-Plant & Equipment	1.38M	1.95M	604K	520K	1.36M	201K	471K	371K	395K	436K	718K	891K	1.27M	1.59M	1.81M	1.46M	1.15M	554K	267K	n/a
Goodwill & Intangibles	n/a	2.63M	9.73M	-33.48M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.88M	5.07M	10.81M	996K	1.84M	753K	1.08M	910K	550K	585K	859K	954K	1.41M	1.76M	1.92M	1.46M	1.15M	554K	267K	n/a
Total Assets	9.03M	16.4M	23.98M	15.24M	11.22M	9.36M	10.08M	15.38M	5.08M	7.54M	15.65M	19.23M	15.96M	15.52M	17.52M	13.97M	23.92M	11.87M	3.56M	1.31M
Account Payables	1.13M	1.08M	1.04M	302K	331K	551K	466K	455K	2.48M	1.86M	1.67M	455K	472K	406K	272K	406K	142K	365K	137K	n/a
Deferred Revenue	n/a	1.81M	1.29M	730K	822K	2.32M	2.84M	2.07M	170K	425K	337K	1.22M	1.3M	1.49M	2.17M	2.5M	3.04M	2.5M	n/a	n/a
Short-Term Debt	1.63M	906K	505K	832K	4.47M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	106K	371K	408K	256K	n/a	n/a	n/a
Other Current Liabilities	1.52M	667K	763K	1.7M	885K	3.15M	1.67M	1.8M	1.98M	1.05M	1.62M	1.5M	1.06M	726K	1.23M	1.91M	1.14M	521K	173K	n/a
Total Current Liabilities	4.28M	4.26M	3.44M	2.83M	5.69M	3.85M	4.98M	4.32M	4.63M	3.35M	3.63M	3.17M	2.84M	2.72M	4.04M	4.48M	4.58M	3.39M	310K	n/a
Long-Term Debt	1.11M	1.59M	246K	87K	505K	n/a	n/a	n/a	1.66M	n/a	n/a	n/a	n/a	n/a	106K	477K	546K	n/a	n/a	n/a
Other Long-Term Liabilities	334K	n/a	10.12M	n/a	4.05M	560K	1.97M	1.97M	1.64M	344K	1.97M	1.34M	2.72M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	1.44M	1.59M	10.37M	87K	4.56M	560K	2.51M	3.96M	5.54M	2.34M	3.51M	2.01M	3.78M	2.3M	140K	2.14M	5.02M	6.67M	n/a	n/a
Total Liabilities	5.72M	5.84M	13.81M	2.92M	10.25M	4.41M	7.49M	8.28M	10.18M	5.69M	7.13M	5.19M	6.62M	5.03M	4.18M	6.62M	9.6M	10.05M	310K	513K
Total Debt	2.74M	2.04M	551K	503K	4.05M	n/a	n/a	n/a	1.66M	n/a	n/a	n/a	n/a	106K	477K	885K	802K	n/a	n/a	n/a
Common Stock	112K	652K	478K	418K	279K	171K	154K	153K	35K	516K	446K	369K	286K	234K	233K	215K	212K	63K	50K	n/a
Retained Earnings	-174.85M	-158.15M	-141.89M	-136.06M	-125.02M	-114.98M	-111.07M	-103.67M	-90.52M	-71.55M	-56.35M	-40.31M	-33.28M	-28.2M	-23.89M	-26.59M	-18.47M	-13.07M	-7.79M	n/a
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	-509K	-243K	-149K	-1.7M	-1.54M	-15K	-13K	-44K	-14K	n/a	-638K	-3K	12K	-4K	n/a
Shareholders Equity	3.31M	10.55M	10.17M	12.32M	973K	4.95M	2.59M	7.1M	-5.1M	1.85M	8.52M	14.05M	9.34M	10.49M	13.35M	7.34M	14.32M	1.81M	3.25M	802K
Total Investments	476K	484K	475K	475K	475K	475K	n/a	n/a	n/a	n/a	2.55M	4.13M	5.71M	1.27M	300K	n/a	11.41M	6.18M	1M	n/a